
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团2026年第一次临时股东会决议公告 | 2026-01-30 | Chinese | |
| 技源集团股份有限公司2026年第一次临时股东会会议资料 | 2026-01-22 | Chinese | |
| 技源集团股份有限公司第二届董事会第八次会议决议公告 | 2026-01-19 | Chinese | |
| 技源集团股份有限公司2026年第一次临时股东会补充公告 | 2026-01-19 | Chinese | |
| 东方证券股份有限公司关于技源集团股份有限公司变更部分募投项目的核查意见 | 2026-01-19 | Chinese | |
| 技源集团股份有限公司关于变更部分募投项目的进展公告 | 2026-01-19 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 39593501 | 技源集团2026年第一次临时股东会决议公告 | 2026-01-30 | Chinese | ||
| 39593496 | 技源集团股份有限公司2026年第一次临时股东会会议资料 | 2026-01-22 | Chinese | ||
| 39593491 | 技源集团股份有限公司第二届董事会第八次会议决议公告 | 2026-01-19 | Chinese | ||
| 39593487 | 技源集团股份有限公司2026年第一次临时股东会补充公告 | 2026-01-19 | Chinese | ||
| 39593483 | 东方证券股份有限公司关于技源集团股份有限公司变更部分募投项目的核查意见 | 2026-01-19 | Chinese | ||
| 39593474 | 技源集团股份有限公司关于变更部分募投项目的进展公告 | 2026-01-19 | Chinese | ||
| 39593467 | 东方证券股份有限公司关于技源集团股份有限公司首次公开发行网下配售限售股上市流通的核查意见 | 2026-01-16 | Chinese | ||
| 39593461 | 技源集团股份有限公司关于首次公开发行网下发行限售股份上市流通的公告 | 2026-01-16 | Chinese | ||
| 39593453 | 技源集团变更部分募集资金投资项目公告 | 2026-01-14 | Chinese | ||
| 39593443 | 技源集团股份有限公司2026年第一次临时股东会通知 | 2026-01-14 | Chinese | ||
| 39593437 | 技源集团股份有限公司第二届董事会第七次会议决议公告 | 2026-01-14 | Chinese | ||
| 39593434 | 东方证券股份有限公司关于技源集团股份有限公司变更部分募投项目的核查意见 | 2026-01-14 | Chinese | ||
| 39593432 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-01-05 | Chinese | ||
| 39593426 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-01-04 | Chinese | ||
|
2025
1 filing
| |||||
| 39593414 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2025-12-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.